News

Home News

20

Jul2022

PDCI Launches Sharing Page for PMPRB Consultation Submissions

/ PMPRB, What's New
On June 30, 2022, PMPRB issued a Notice and Comment which published its Proposed Interim Guidance and invited ... Read More

30

Jun2022

PMPRB Updates: Proposed Interim Guidelines Published

/ News, PMPRB
PMPRB Launches Consultation on its Proposed Interim Guidance Today, June 30, 2022, PMPRB published a ... Read More

28

Jun2022

PDCI welcomes François-Xavier Houde to the Team
 

/ News, What's New
François-Xavier has joined PDCI Market Access as a Senior Health Economist. He is responsible for ... Read More

05

May2022

CADTH Update: Advice on Real-World Evidence (RWE) by Scientific Advice Program

/ CADTH, News, What's New
On May 3, 2022, CADTH announced the mandate expansion of the Scientific Advice Program to include advice on ... Read More

25

Apr2022

The PMPRB to consult on a different set of guidelines

/ PMPRB, What's New
On April 14, 2022, Health Canada announced that the government will:  Proceed only with the proposed amendments to ... Read More

11

Apr2022

CADTH: New Clinical Evidence Template Requirement for October 2022 Submissions

/ CADTH, News
The Canadian Agency for Drugs and Technologies in Health (CADTH) has published Issue 28 of its Pharmaceutical Reviews ... Read More

04

Apr2022

PMPRB 2020 Annual Report Shows Almost 30% Decrease in New Patented Medicines Reported Since 2018

/ PMPRB, What's New
On March 31, 2022, PMPRB published its 2020 Annual Report on its website. Key statistics reinforce concerns about ... Read More

25

Mar2022

Supreme Court Dismisses Attorney General’s Application for Leave to Appeal FCA decision in PMPRB Alexion Soliris Matter

/ News, PMPRB, What's New
On September 29, 2021, the Attorney General of Canada applied for leave to appeal to the Supreme Court ... Read More